BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 15922378)

  • 1. Histopathogenesis of experimental Mycobacterium bovis infection in mice.
    Chambers MA; Gavier-Widen D; Hewinson RG
    Res Vet Sci; 2006 Feb; 80(1):62-70. PubMed ID: 15922378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation of Mycobacterium bovis: I. Pathology and bacteriology.
    Corner LA; Costello E; Lesellier S; O'Meara D; Sleeman DP; Gormley E
    Res Vet Sci; 2007 Aug; 83(1):53-62. PubMed ID: 17197004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive and fatal infection with attenuated Mycobacterium bovis (BCG) in nude mice.
    Ueda K; Yamazaki S; Saegusa J; Someya S
    Jpn J Exp Med; 1978 Dec; 48(6):533-43. PubMed ID: 374803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior virulence of Mycobacterium bovis over Mycobacterium tuberculosis (Mtb) for Mtb-resistant and Mtb-susceptible mice is manifest as an ability to cause extrapulmonary disease.
    Medina E; Ryan L; LaCourse R; North RJ
    Tuberculosis (Edinb); 2006 Jan; 86(1):20-7. PubMed ID: 16253563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody bound to the surface antigen MPB83 of Mycobacterium bovis enhances survival against high dose and low dose challenge.
    Chambers MA; Gavier-Widén D; Hewinson RG
    FEMS Immunol Med Microbiol; 2004 Jun; 41(2):93-100. PubMed ID: 15145452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
    Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
    Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
    Fan X; Gao Q; Fu R
    Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ.
    North RJ; Izzo AA
    Am J Pathol; 1993 Jun; 142(6):1959-66. PubMed ID: 8506962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental tuberculosis in the European badger (Meles meles) after endobronchial inoculation with Mycobacterium bovis: II. Progression of infection.
    Corner LA; Costello E; Lesellier S; O'Meara D; Gormley E
    Res Vet Sci; 2008 Dec; 85(3):481-90. PubMed ID: 18433810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on tubercle bacillus infection in germ-free mice.
    Ueda K; Yamazaki S; Someya S
    J Reticuloendothel Soc; 1972 Nov; 12(5):545-63. PubMed ID: 4676283
    [No Abstract]   [Full Text] [Related]  

  • 12. Infection of Arvicola terrestris (vole rat) with M. tuberculosis and M. bovis.
    Jespersen A
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Oct; 82B(5):667-75. PubMed ID: 4215283
    [No Abstract]   [Full Text] [Related]  

  • 13. Septicemic infection in nude mice caused by a virulent strain of Mycobacterium bovis.
    Ueda K; Yamazaki S; Saegusa J; Someya S
    Jpn J Exp Med; 1977 Dec; 47(6):467-74. PubMed ID: 344950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemolytic activity of Mycobacterium spp.
    Brzychcy M; Andrzejczyk Z; Zalewska N; Zwolska Z; Rudnicka W
    Acta Microbiol Pol; 1997; 46(4):377-85. PubMed ID: 9516984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The virulence for mice of newly described mycobacterial species].
    Saito H; Murakami K; Yajima M; Ishii N; Kwon HH
    Kekkaku; 2000 Feb; 75(2):65-9. PubMed ID: 10723938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The response of the fibrinolytic system to mycobacteria infection.
    Rodríguez-Flores E; Campuzano J; Aguilar D; Hernández-Pando R; Espitia C
    Tuberculosis (Edinb); 2012 Nov; 92(6):497-504. PubMed ID: 22885283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
    Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
    Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Animal models of tuberculosis.
    Gupta UD; Katoch VM
    Tuberculosis (Edinb); 2005; 85(5-6):277-93. PubMed ID: 16249122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new attenuated Mycobacterium bovis vaccine protects brushtail possums (Trichosurus vulpecula) against experimental tuberculosis infection.
    Collins DM; de Lisle GW; Aldwell FE; Buddle BM
    Vaccine; 2007 Jun; 25(24):4659-64. PubMed ID: 17498852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental exposure of cattle to a precise aerosolised challenge of Mycobacterium bovis: a novel model to study bovine tuberculosis.
    Rodgers JD; Connery NL; McNair J; Welsh MD; Skuce RA; Bryson DG; McMurray DN; Pollock JM
    Tuberculosis (Edinb); 2007 Sep; 87(5):405-14. PubMed ID: 17602870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.